TY - JOUR
T1 - Understanding the Reasons Why Mothers Do or Do Not Have Their Adolescent Daughters Vaccinated Against Human Papillomavirus
AU - Dempsey, Amanda F.
AU - Abraham, Leah M.
AU - Dalton, Vanessa
AU - Ruffin, Mack
N1 - Funding Information:
This study provides insight in the postlicensure era into the reasons why mothers accept or decline HPV vaccination for their daughters. Using qualitative methods, we identified a wide range of reasons that factor into this decision. One of these, control over health-related decisions, had not been described previously in the context of HPV vaccination. The decision to decline the vaccine appeared modifiable, with many mothers seemingly agreeable to vaccination when their daughter was older, more likely to be sexually active or when additional safety information for the vaccine was available. These findings may help to inform future interventions aimed at improving adherence to HPV vaccination recommendations. This work was supported by the 2007 Elizabeth E. Kennedy Award and the Bridging Interdisciplinary Research Careers in Women's Health (BIRCWH) program at the University of Michigan, Ann Arbor.
PY - 2009/8
Y1 - 2009/8
N2 - Purpose: The objective of this study was to compare the reasons why mothers do or do not have their adolescent daughters vaccinated against HPV. Methods: Mothers of vaccinated and unvaccinated 11- to 17-year-old girls seen during preventive care visits in outpatient family medicine or pediatric clinics underwent an audiotaped structured telephone interview that used open-ended questions to assess the reasons underlying maternal decisions about HPV vaccination. Qualitative methods categorized maternal responses into themes. Results: Interviews of 52 mothers (19 declining vaccination, 33 accepting) identified several distinct factors underlying their decisions about HPV vaccination. Lack of knowledge about HPV, age-related concerns, and low perceived risk of infection were commonly cited reasons for declining vaccination. Desire to prevent illness, physician recommendation, and a high perceived risk of infection were commonly identified motivating factors. Both groups of mothers had significant concerns about vaccine safety. Locus of control (e.g., mother or daughter) of health-related decisions arose as a novel factor influencing this decision that had not been previously described in the context of HPV vaccination. Conclusions: Addressing safety concerns, educating parents about the age-specific risk of HPV infection, and promoting strong physician recommendation for vaccination may be the most useful targets for future interventions to increase HPV vaccine utilization.
AB - Purpose: The objective of this study was to compare the reasons why mothers do or do not have their adolescent daughters vaccinated against HPV. Methods: Mothers of vaccinated and unvaccinated 11- to 17-year-old girls seen during preventive care visits in outpatient family medicine or pediatric clinics underwent an audiotaped structured telephone interview that used open-ended questions to assess the reasons underlying maternal decisions about HPV vaccination. Qualitative methods categorized maternal responses into themes. Results: Interviews of 52 mothers (19 declining vaccination, 33 accepting) identified several distinct factors underlying their decisions about HPV vaccination. Lack of knowledge about HPV, age-related concerns, and low perceived risk of infection were commonly cited reasons for declining vaccination. Desire to prevent illness, physician recommendation, and a high perceived risk of infection were commonly identified motivating factors. Both groups of mothers had significant concerns about vaccine safety. Locus of control (e.g., mother or daughter) of health-related decisions arose as a novel factor influencing this decision that had not been previously described in the context of HPV vaccination. Conclusions: Addressing safety concerns, educating parents about the age-specific risk of HPV infection, and promoting strong physician recommendation for vaccination may be the most useful targets for future interventions to increase HPV vaccine utilization.
UR - http://www.scopus.com/inward/record.url?scp=67649359748&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67649359748&partnerID=8YFLogxK
U2 - 10.1016/j.annepidem.2009.03.011
DO - 10.1016/j.annepidem.2009.03.011
M3 - Article
C2 - 19394865
AN - SCOPUS:67649359748
SN - 1047-2797
VL - 19
SP - 531
EP - 538
JO - Annals of Epidemiology
JF - Annals of Epidemiology
IS - 8
ER -